vs
林肯电气（LECO）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是林肯电气的1.3倍（$1.4B vs $1.1B），瑞思迈净利率更高（27.6% vs 12.2%，领先15.4%），林肯电气同比增速更快（11.7% vs 11.0%），过去两年瑞思迈的营收复合增速更高（7.8% vs 4.8%）
林肯电气是美国跨国焊接产品制造企业，总部位于俄亥俄州欧几里得市，主营弧焊设备、焊接配件、等离子及氧燃料切割设备、焊接机器人系统等，业务覆盖160余个国家和地区，在全球设有42个生产基地，同时在19个国家布局了生产联盟及合资企业。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
LECO vs RMD — 直观对比
营收规模更大
RMD
是对方的1.3倍
$1.1B
营收增速更快
LECO
高出0.7%
11.0%
净利率更高
RMD
高出15.4%
12.2%
两年增速更快
RMD
近两年复合增速
4.8%
损益表 — Q1 FY2026 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $136.4M | $392.6M |
| 毛利率 | 35.6% | 61.8% |
| 营业利润率 | 16.6% | 34.6% |
| 净利率 | 12.2% | 27.6% |
| 营收同比 | 11.7% | 11.0% |
| 净利润同比 | 15.1% | 13.9% |
| 每股收益（稀释后） | $2.47 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LECORMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $1.1B | $1.4B | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.3B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.0B | $1.3B | ||
| Q3 24 | $983.8M | $1.2B |
净利润LECORMD
| Q2 26 | — | $392.6M | ||
| Q1 26 | $136.4M | $398.7M | ||
| Q4 25 | $136.0M | $392.6M | ||
| Q3 25 | $122.6M | $348.5M | ||
| Q2 25 | $143.4M | $379.7M | ||
| Q1 25 | $118.5M | $365.0M | ||
| Q4 24 | $140.2M | $344.6M | ||
| Q3 24 | $100.8M | $311.4M |
毛利率LECORMD
| Q2 26 | — | 61.8% | ||
| Q1 26 | 35.6% | 62.2% | ||
| Q4 25 | 34.7% | 61.8% | ||
| Q3 25 | 36.7% | 61.5% | ||
| Q2 25 | 37.3% | 60.8% | ||
| Q1 25 | 36.4% | 59.3% | ||
| Q4 24 | 36.1% | 58.6% | ||
| Q3 24 | 35.8% | 58.6% |
营业利润率LECORMD
| Q2 26 | — | 34.6% | ||
| Q1 26 | 16.6% | 34.9% | ||
| Q4 25 | 17.1% | 34.6% | ||
| Q3 25 | 16.6% | 33.4% | ||
| Q2 25 | 17.6% | 33.7% | ||
| Q1 25 | 16.4% | 33.0% | ||
| Q4 24 | 17.3% | 32.5% | ||
| Q3 24 | 14.8% | 31.6% |
净利率LECORMD
| Q2 26 | — | 27.6% | ||
| Q1 26 | 12.2% | 27.9% | ||
| Q4 25 | 12.6% | 27.6% | ||
| Q3 25 | 11.6% | 26.1% | ||
| Q2 25 | 13.2% | 28.2% | ||
| Q1 25 | 11.8% | 28.3% | ||
| Q4 24 | 13.7% | 26.9% | ||
| Q3 24 | 10.2% | 25.4% |
每股收益（稀释后）LECORMD
| Q2 26 | — | $2.68 | ||
| Q1 26 | $2.47 | $2.74 | ||
| Q4 25 | $2.45 | $2.68 | ||
| Q3 25 | $2.21 | $2.37 | ||
| Q2 25 | $2.56 | $2.58 | ||
| Q1 25 | $2.10 | $2.48 | ||
| Q4 24 | $2.47 | $2.34 | ||
| Q3 24 | $1.77 | $2.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $298.9M | $1.4B |
| 总债务越低越好 | $1.3B | $663.8M |
| 股东权益账面价值 | $1.5B | $6.3B |
| 总资产 | $3.9B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.87× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资LECORMD
| Q2 26 | — | $1.4B | ||
| Q1 26 | $298.9M | $1.7B | ||
| Q4 25 | $308.8M | $1.4B | ||
| Q3 25 | $293.0M | $1.4B | ||
| Q2 25 | $299.5M | $1.2B | ||
| Q1 25 | $394.7M | $932.7M | ||
| Q4 24 | $377.3M | $521.9M | ||
| Q3 24 | $404.2M | $426.4M |
总债务LECORMD
| Q2 26 | — | $663.8M | ||
| Q1 26 | $1.3B | $664.1M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | — | $408.7M | ||
| Q2 25 | — | $658.4M | ||
| Q1 25 | — | $663.1M | ||
| Q4 24 | — | $662.9M | ||
| Q3 24 | — | $667.6M |
股东权益LECORMD
| Q2 26 | — | $6.3B | ||
| Q1 26 | $1.5B | $6.5B | ||
| Q4 25 | $1.5B | $6.3B | ||
| Q3 25 | $1.4B | $6.1B | ||
| Q2 25 | $1.4B | $6.0B | ||
| Q1 25 | $1.3B | $5.5B | ||
| Q4 24 | $1.3B | $5.3B | ||
| Q3 24 | $1.3B | $5.2B |
总资产LECORMD
| Q2 26 | — | $8.5B | ||
| Q1 26 | $3.9B | $8.8B | ||
| Q4 25 | $3.8B | $8.5B | ||
| Q3 25 | $3.8B | $8.3B | ||
| Q2 25 | $3.7B | $8.2B | ||
| Q1 25 | $3.6B | $7.6B | ||
| Q4 24 | $3.5B | $7.1B | ||
| Q3 24 | $3.7B | $7.2B |
负债/权益比LECORMD
| Q2 26 | — | 0.11× | ||
| Q1 26 | 0.87× | 0.10× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $102.2M | — |
| 自由现金流经营现金流 - 资本支出 | $63.0M | — |
| 自由现金流率自由现金流/营收 | 5.6% | — |
| 资本支出强度资本支出/营收 | 3.5% | — |
| 现金转化率经营现金流/净利润 | 0.75× | — |
| 过去12个月自由现金流最近4个季度 | $438.5M | — |
8季度趋势，按日历期对齐
经营现金流LECORMD
| Q2 26 | — | — | ||
| Q1 26 | $102.2M | — | ||
| Q4 25 | $95.0M | $339.7M | ||
| Q3 25 | $236.7M | $457.3M | ||
| Q2 25 | $143.8M | $538.8M | ||
| Q1 25 | $185.7M | $578.7M | ||
| Q4 24 | $95.8M | $308.6M | ||
| Q3 24 | $199.2M | $325.5M |
自由现金流LECORMD
| Q2 26 | — | — | ||
| Q1 26 | $63.0M | — | ||
| Q4 25 | $52.0M | $311.2M | ||
| Q3 25 | $205.1M | $414.4M | ||
| Q2 25 | $118.4M | $508.2M | ||
| Q1 25 | $158.7M | $557.9M | ||
| Q4 24 | $64.3M | $288.0M | ||
| Q3 24 | $163.5M | $307.7M |
自由现金流率LECORMD
| Q2 26 | — | — | ||
| Q1 26 | 5.6% | — | ||
| Q4 25 | 4.8% | 21.9% | ||
| Q3 25 | 19.3% | 31.0% | ||
| Q2 25 | 10.9% | 37.7% | ||
| Q1 25 | 15.8% | 43.2% | ||
| Q4 24 | 6.3% | 22.5% | ||
| Q3 24 | 16.6% | 25.1% |
资本支出强度LECORMD
| Q2 26 | — | — | ||
| Q1 26 | 3.5% | — | ||
| Q4 25 | 4.0% | 2.0% | ||
| Q3 25 | 3.0% | 3.2% | ||
| Q2 25 | 2.3% | 2.3% | ||
| Q1 25 | 2.7% | 1.6% | ||
| Q4 24 | 3.1% | 1.6% | ||
| Q3 24 | 3.6% | 1.5% |
现金转化率LECORMD
| Q2 26 | — | — | ||
| Q1 26 | 0.75× | — | ||
| Q4 25 | 0.70× | 0.87× | ||
| Q3 25 | 1.93× | 1.31× | ||
| Q2 25 | 1.00× | 1.42× | ||
| Q1 25 | 1.57× | 1.59× | ||
| Q4 24 | 0.68× | 0.90× | ||
| Q3 24 | 1.98× | 1.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
